Metraipolis › archive › dc_9dd3e07b03eb

Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study — Europe PMC PMID:41899626

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41899626
DOI
10.3390/cancers18061025
License (as archived)
solo-consultazione
Archived
2026-11-04T03:00:24.107Z
SHA-256 of the archived text
97ad3f9fa6fa90219e717035c896be09b790cbff4ee35b39dec16eb6839f7386
Stable URL of this page
https://metraipolis.com/documento/dc_9dd3e07b03eb

How to cite

Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study — Europe PMC PMID:41899626 — Europe PMC (en), https://europepmc.org/article/MED/41899626 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9dd3e07b03eb (Metraipolis archive dc_9dd3e07b03eb, sha256 97ad3f9fa6fa90219e717035c896be09b790cbff4ee35b39dec16eb6839f7386)
BibTeX
@misc{dc9dd3e07b03eb,
  title = {Efficacy and Safety of Dalpiciclib in HR-Positive Advanced Breast Cancer: A Two-Center Retrospective Study — Europe PMC PMID:41899626},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41899626},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9dd3e07b03eb; sha256 97ad3f9fa6fa90219e717035c896be09b790cbff4ee35b39dec16eb6839f7386},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41899626. Agents can read the archived copy with the MCP tool read_document.